Capital Fund Management (CFM)
NTLA icon

Capital Fund Management (CFM)’s Intellia Therapeutics NTLA Stock Holding History

Capital Fund Management (CFM)’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.36M Buy
730,122
+537,096
+278% +$6.84M 0.08% 580
2025
Q4 		$1.74M Buy
193,026
+2,628
+1% +$36.2K 0.02% 1772
2025
Q3 		$3.29M Sell
190,398
-181,209
-49% -$2.23M 0.03% 1508
2025
Q2 		$3.49M Buy
371,607
+235,353
+173% +$1.93M 0.04% 1367
2025
Q1 		$969K Buy
+136,254
New +$1.38M 0.01% 1680
2024
Q4 		– Sell
-18,705
Closed -$292K – 2364
2024
Q3 		$384K Buy
+18,705
New +$431K ﹤0.01% 1881
2024
Q2 		– Sell
-92,578
Closed -$2.2M – 2298
2024
Q1 		$2.55M Buy
+92,578
New +$2.57M 0.03% 1339
2023
Q4 		– Hold
0
– – – 2430
2023
Q3 		– Hold
0
– – – 2218
2023
Q2 		– Sell
-107,656
Closed -$4.01M – 2006
2023
Q1 		$4.01M Sell
107,656
-2,233
-2% -$87.6K 0.08% 807
2022
Q4 		$3.83M Buy
+109,889
New +$5.22M 0.08% 715
2021
Q2 		– Hold
0
– – – 1704
2021
Q1 		– Hold
0
– – – 1634

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $47.9M AUM 29.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return